Correlates of thymus size and changes during treatment of children with severe acute malnutrition: a cohort study
© The Author(s). 2017
Received: 9 April 2016
Accepted: 24 February 2017
Published: 14 March 2017
The impairment of immune functions associated with malnutrition may be one reason for the high mortality in children with severe acute malnutrition (SAM), and thymus atrophy has been proposed as a marker of this immunodeficiency. The aim of this study was to identify nutritional and clinical correlates of thymus size in children with SAM, and predictors of change in thymus size with nutritional rehabilitation.
In an observational study among children aged 6–59 months admitted with SAM in Uganda, we measured thymus area by ultrasound on hospital admission to treatment with F75 and F100, on hospital discharge and after 8 weeks of nutritional rehabilitation with ready-to-use therapeutic food, as well as in well-nourished healthy children. We investigated anthropometric, clinical, biochemical and treatment-related correlates of area and growth of the thymus.
Eighty-five children with SAM with a median age of 16.5 months were included. On admission 27% of the children had a thymus undetectable by ultrasound. Median thymus area was 1.3 cm2 in malnourished children, and 3.5 cm2 in healthy children (p < 0.001). Most anthropometric z-scores, hemoglobin and plasma phosphate correlated positively with thymus area. Thymus area correlated negatively with caretaker-reported severity of illness, plasma α-1 acid glycoprotein, and C-reactive protein >5 mg/L. At follow-up after 8 weeks, median thymus area had increased to 2.5 cm2 (p < 0.001). Increase in thymus area during treatment was associated with simultaneous increase in mid-upper-arm circumference, with 0.29 cm2 higher increase in thymus area per cm larger increment in MUAC (p = 0.03). Children whose F-75 had partially been replaced by rice porridge during their hospital admission had less increase in thymus area after 8 weeks.
Malnutrition and inflammation are associated with thymus atrophy, and thymus area seems positively associated with plasma phosphate. Substituting therapeutic formula with unfortified rice porridge with the aim of alleviating diarrhea may impair regain of thymus size with nutritional rehabilitation. This calls for research into possible effects of phosphate status on thymus size and other immunological markers.
The study is based on data from the FeedSAM study, ISRCTN55092738.
KeywordsRe-feeding Immune function Undernutrition Thymus Electrolytes Inflammation Phosphate
Severe acute malnutrition (SAM) in children is a life-threatening condition , and many hospitals in sub-Saharan Africa report mortality rates above 20% in children admitted with SAM . The reasons for the high mortality are not clear, but most deaths are attributable to infectious diseases, probably facilitated by impaired immune function in the malnourished children . Although the mechanism behind the immune deficiency of malnutrition is still poorly understood, one immunological alteration consistently reported in malnourished children is atrophy of the thymus [4–6]. As such, the size of the thymus has been suggested to be a marker of the immunodeficiency of malnutrition . Even in absence of severe acute malnutrition, thymus size is associated with nutritional status, and independently of nutritional status, children with a small thymus have higher mortality [7, 8]. Although it is unknown to which extend thymus size reflects immune competence, the observations suggest that thymus size may be a marker of robustness in small children. This could potentially make it highly relevant to study in children with SAM, who are extremely vulnerable in the first place.
Even though malnourished children are known to have thymus atrophy, it is unknown how this is modified by clinical factors, such as edema, anemia, electrolyte disturbances, Human Immunodeficiency Virus (HIV), other infections or inflammation in general. Furthermore, although previous studies have documented that thymus atrophy is reversible when malnutrition is treated [5, 6], little is known about what determines thymus growth with nutritional rehabilitation. The aim of this study was therefore to investigate clinical factors associated with thymus size in children admitted for in-hospital treatment of SAM, and predictors of growth in thymus size with nutritional rehabilitation.
This study was an observational study among children admitted for in-hospital treatment of SAM between October 2012 and January 2013. The study was nested within the FeedSAM study, investigating physiological changes in children hospitalized with SAM, primarily change in plasma phosphate (P-phosphate). The FeedSAM study was registered in the ISRCTN registry with the number ISRCTN55092738.
Study site and standard treatment
Mwanamugimu Nutrition Unit at Mulago Hospital is the main treatment center for children with complicated SAM in Uganda. At the time of the study, all children received in-patient treatment based on the Ugandan National Protocol for the Integrated Management of Acute Malnutrition, using World Health Organization (WHO)-recommended milk-based diets, F-75 and F-100 (Nutriset, France), as well as empiric parenteral antibiotics, usually ampicillin and gentamycin . Dehydration was treated with oral rehydration solution for malnourished children (ReSoMal, Nutriset, France). When children were clinically well they were discharged to outpatient treatment with ready-to-use therapeutic food . All biological mothers were offered routine counseling and testing for HIV antibodies, and if the mother was positive or absent, the child was tested. Antibody-positive children aged <18 months were referred for with PCR-based testing, according to WHO guidelines . Diarrhea is a major concern at the unit, and at the time of the study, F-75 or F-100 were occasionally replaced with unfortified rice porridge for some days, when children had or developed diarrhea, and intolerance to the milk-based feeds was suspected.
Inclusion and exclusion criteria
Inclusion criteria of children were: age 6–59 months; admission on weekdays for treatment of SAM, defined as either weight-for-length z-score (WLZ) < −3, using WHO Growth Standard , or mid-upper arm circumference (MUAC) <11.5 cm, or bilateral pitting edema; living close to the hospital; and a guardian providing informed consent. Exclusion criteria were: significant disability; manifest shock or severe respiratory distress requiring resuscitation at admission; hemoglobin <4 g/dl or a body weight <4.5 kg. Severe infections such as sepsis, HIV or tuberculosis were not reasons for exclusion. Inclusion and follow-up measurements were only possible when MJHR was present to perform the ultrasound measurements.
At admission, we obtained information about the child’s current symptoms and history using a structured questionnaire. Caretakers were asked to rate the perceived severity of their child’s illness on a visual analogue scale (VAS) from 1 to 10. Vital signs were noted (axillary temperature, pulse, respiratory rate, and capillary refill time), as well as edema and oral thrush. To assess appetite, we noted whether the child was able to consume all of the first served therapeutic feed.
Body weight was measured daily on a digital scale, to the nearest 100 g. Length and MUAC were measured to the nearest one mm, using an infant length board, and measurement tape, respectively. For analysis, anthropometric z-scores were computed using WHO Growth Standards . In order to obtain the “true” body weight, after loss of edema, we used the lowest weight recorded after admission. We took into account that length was measured in all children by subtracting 0,7 cm from length measurements in children older than 2 years.
Study staff monitored children daily (on weekdays), recording weight, frequency and consistence of stools, type and amount of feed given, whether ReSoMal was given, and whether a naso-gastric tube was used for feeding. Children were classified as having diarrhea when passing three or more loose or watery stools per day.
Thymus area measurement
Blood samples relevant to this study were collected from a peripheral vein at three time points: Sample one at admission before starting refeeding; sample two approximately 48 h after starting refeeding; and sample three, at the day of discharge to outpatient treatment. On all three occasions, 1 ml was collected in heparinized evacuated tubes, and on admission and discharge, 5 ml was also collected in a Cell Preparation Vacutainer® with citrate (Becton Dickinson, USA).
At admission and discharge, hemoglobin level was measured in heparinized full blood, using HemoCue® (Hb 201+, Ängelholm, Sweden). Citrate plasma was frozen at −80 Co, and shipped to Denmark on dry ice, where C-reactive protein (CRP) and α1-acid-glycoprotein (AGP), were measured at University of Copenhagen, Department of Nutrition, Exercise and Sports, using ABX Pentra® 400 (HORIBA, France). Heparinized plasma from all three time points was frozen to −20 Co for up to 2 months, and inorganic phosphate (P-phosphate) was measured at Ebenezer Ltd Clinical Laboratory in Kampala (ISO 15189, Laboratory No. M0221), using molybdate UV method (Cobas Integra® 400 Plus).
Apparently healthy children, with WLZ > −1 and aged 6–59 months, were recruited among children of hospital staff and siblings of hospitalized children and examined once. Thymus area assessment, physical examination, anthropometric measurements and blood sampling was done in controls, as described for the study patients.
Data were entered into EpiData (Odense, Denmark) and analyzed using Stata version 12 (StataCorp LP, College station, Texas, USA). Normally distributed variables were expressed as means ± standard deviations (SD), and variables that did not follow a normal distribution were expressed at medians and interquartile ranges (IQR). Two-sample t-tests were used to evaluate differences in means except in case of non-normally distributed outcomes where Mann-Whitney rank-sum- tests were used. Chi-square tests were used to compare proportions, except when the expected numbers were less than five, in which case Fisher’s exact test was used.
To identify correlates of thymus area on admission, while including children with an invisibly small thymus, we used an analysis of covariance (ANCOVA) allowing for left-censored measurements from children with an invisibly small thymus. Since area measurements <1 cm2 may be less accurate, we assigned all children with an undetectable thymus and children with measured area <1 cm2 to an unknown low value <1 cm2, and such left—censored measurements received less weight in the analysis as compared to accurately observed measurements, using the command “tobit” in Stata. Thymus area did not follow a normal distribution, and hence was logarithm-transformed (base 10); estimates were subsequently back-transformed. The analysis was adjusted for age and sex.
ANCOVA was also used to evaluate predictors of growth in thymus area at discharge and follow-up, defined as the change in thymus area (Δ thymus area = thymus area at follow-up – thymus area at admission). These analyses were adjusted for age, sex, number of days since first scan and thymus area on admission. Children with an undetectable thymus on admission were assigned a thymus area of 1 cm2 in order to calculate the change in thymus area over time.
As sensitivity analyses, we firstly analyzed correlates of thymus area and of predictors of growth in thymus area while only including children with a visible thymus, and without left-censoring of low values. Secondly, to assess if the associations were explained by body size, we analyzed correlates of thymus size while adjusting for body weight after loss of edema.
Anthropometric, clinical and biochemical characteristics of 85 children admitted with severe acute malnutrition by visibility of the thymusa
Thymus not visible
n = 63
n = 22
16.0 (12.8; 22.7)
17.3 (13.2; 22.7)
Mid-upper arm circumference, cm
11.7 ± 1.4
11.6 ± 1.2
−3.4 ± 1.5
−3.5 ± 1.3
−3.9 ± 1.2
−3.9 ± 1.1
−3.1 ± 1.4
−3.0 ± 1.4
Symptoms reported by caretaker
How sick according to caretakerd
6.4 ± 1.7
7.5 ± 2.2
138 ± 22
138 ± 21
38 ± 11
37 ± 10
Capillary refill time, sec
1.9 ± 0.8
2.1 ± 1.1
Temperature >37.5 °C
Able to complete first feed
9.1 ± 2.3
8.7 ± 2.3
C-reactive protein, mg/L
19.4 (7.9; 37.3)
19.6 (12.8; 23.8)
> 5 mg/L
α1-acid glycoprotein, g/L
2.24 ± 0.72
2.73 ± 0.66
138 ± 4
140 ± 5
4.2 ± 0.7
4.0 ± 0.9
Inorganic phosphate, mmol/L
1.07 ± 0.31
1.03 ± 0.29
1.55 ± 0.37
1.30 ± 0.35
Change during first two days
0.50 ± 0.38
0.31 ± 0.31
Of the 85 children scanned at admission, 54 were scanned at discharge, meaning that 31 were lost before discharge: 13 children died, 13 self-discharge before recommended, and five were discharged when the person performing the scans was not present at the unit. Before follow-up, another 20 children were lost from the study; 5 because they did not show up at follow-up, and 15 because the examiner was not present on the day of follow-up, leaving 34 with complete data at all three time points of the study (Fig. 4).
A greater proportion of those lost to follow-up were boys, while they did not differ significantly in terms of anthropometry, age, HIV-infection or acute-phase reactants. More of those lost to follow-up had an undetectable thymus on admission (35% vs. 12%, p = 0.02), but among those where it could be measured, thymus area was not different from those remaining in the study.
Correlates of thymus size on admission
Among malnourished children with a visible thymus, thymus area ranged from 0.6 to 5.4 cm2, with a median of 1.3 cm2 on admission. In control children, thymus area ranged from 2.4 to 5.3 cm2, with a median of 3.5 cm2 (p < 0.001).
Linear regression identifying factors associated with thymus areaa on admission among 85 children admitted with severe acute malnutrition. Invisible thymuses and values <1 cm2 censored as “below detection limit”b
10β (95% confidence interval)
1.18 (0.90; 1.54)
0.99 (0.98; 1.01)
1.22 (0.93; 1.58)
1.09 (0.93; 1.58)
Mid-upper arm circumference, cm
1.11 (1.01; 1.21)
1.13 (1.02; 1.25)
1.07 (0.97; 1.19)
Clinical data, admission
0.73 (0.53; 1.01)
Symptoms reported by caretaker
0.86 (0.65; 1.13)
0.86 (0.66; 1.12)
0.97 (0.73; 1.29)
How sick according to caretakere
0.89 (0.83; 0.95)
Physical examination on admission
1.00 (0.99; 1.00)
Respiratory rate, breaths/minute
1.00 (0.99; 1.00)
Capillary refill time, seconds
0.97 (0.84; 1.12)
0.80 (0.60; 1.08)
Oral thrush present
0.88 (0.98; 1.69)
Able to complete first feed
1.19 (0.86; 1.66)
Blood chemistry on admissionf
1.08 (1.02; 1.14)
C-reactive protein > 5 mg/L
0.61 (0.41; 0.89)
α1-acid glycoprotein, g/L
0.73 (0.60; 0.90)
0.99 (0.96; 1.02)
1.01 (0.85; 1.21)
Inorganic phosphate, mmol/L
1.50 (0.99; 2.27)
1.66 (1.24; 2.20)
In the first sensitivity analysis, only including children with a visible thymus, we found overall similar associations. In the second sensitivity analysis, adjusting for body weight, age and sex, the associations were also similar, except there was no longer any significant association with WLZ or weight-for-age z-score (not shown in tables).
Increase in thymus area
Thymus size and other characteristics in children during treatment of severe acute malnutrition, and in a group of healthy childrena
Malnourished children during treatment
No. of children scanned
No. of children with visible thymus
Thymus area, cm2 b
1.3 (1.0; 1.7)
1.6 (1.4; 2.1)
2.5 (2.1; 3.3)
3.5 (3.1; 3.8)
Time from admission scanned, days
1 (1; 1)
14 (12; 20)
56 (50; 57)
Time admitted, days
Weight gain, g/kg/day
5.9 (3.7; 8.3)
4.7 (3.0; 6.4)
6.8 ± 1.5
7.6 ± 1.4
8.5 ± 1.3
72.7 ± 5.7
72.2 ± 5.2
73.6 ± 5.6
80.7 ± 9.3
- 3.9 ± 1.2
- 3.1 ± 1.1
−2.2 ± 1.0
0.0 ± 1.0
- 3.1 ± 1.4
−3.4 ± 1.2
−3.2 ± 1.1
−0.9 ± 1.2
- 3.4 ± 1.4
- 1.78 ± 1.1
−0.7 ± 0.9
0.6 ± 0.9
< −2 and > −3
< − 3
Mid-upper arm circumference, cm
11.6 ± 1.4
12.0 ± 1.1
12.9 ± 1.1
16.0 (13.0; 22.7)
16.7 (13.5; 23.9)
17.8 (14.9; 26.0)
20.6 (12.0; 34.4)
9.0 ± 2.3
9.7 ± 1.9
10.2 ± 1.5
Plasma C-reactive protein, mg/L
19.6 (8.8; 31.2)
0.4 (0.2; 1.9)
Plasma α1-acid glycoprotein, g/L
2.37 ± 0.73
1.09 ± 0.39
0.83 ± 0.30
Correlates of change in thymus size from admission to discharge and to follow-up among children treated for severe acute malnutritiona
β (95% CI)
−0.06 (−0.65; 0.53)
0.01 (−0.01; 0.03)
- 0.02 (−0.06; 0.01)
Days from admission
0.02 (−0.01; 0.04)
0.00 (−0.04; 0.05)
Clinical data, admission
−0.34 (−0.97; 0.29)
0.09 (−0.38; 0.55)
0.35 (−0.60; 1.31)
0.25 (−0.66; 1.17)
How sick according to caretakerc
0.04 (−0.05; 0.13)
Physical examination, admission
0.01 (−0.43; 0.45)
0.10 (−0.66; 0.86)
Capillary refill time, sec
−0.05 (−0.24; 0.14)
0.14 (−0.34; 0.62)
Able to complete first feed
−0.04 (−0.40; 0.32)
0.35 (−0.45; 1.15))
Blood chemistry, admission
C-reactive protein >5 mg/L
0.36 (−0.07; 0.79)
−0.22 (−1.16; 0.72)
α1-acid glycoprotein, g/L
0.03 (−0.24; 0.31)
−0.60 (−1.12; −0.08)
0.08 (0.01; 0.15)
−0.00 (−0.14; 0.13)
Inorganic phosphate, mmol/L
0.16 (−0.34; 0.66)
0.12 (−1.01; 1.24)
Anthropometric growth in same period
Weight gain rate, kg/dayd
5.77 (−1.20; 12.74)
14.02 (−8.12; 36.15)
Δ mid-upper arm circumference, cm
0.29 (0.04; 0.54)
Δ weight-for-length z-scored
−0.02 (−0.20; 0.17)
0.08 (−0.19; 0.34)
Δ weight-for-age z-scored
0.08 (−0.25; 0.41)
0.22 (−0.20; 0.63)
Observations and treatments given during admission
- 0.10 (−0.44; 0.25)
0.10 (−0.52; 0.71)
Rice porridge given
−0.11 (−0.42; 0.19)
−0.67 (−1.28; −0.05)
Naso-gastric tube used
−0.08 (−0.44; 0.28)
−0.25 (−0.92; 0.42)
Thymus atrophy has previously been reported among malnourished children, based on autopsy studies  and in ultrasound studies [5, 6]. It has been hypothesized that thymus atrophy could reflect the immune deficiency of malnutrition, causing greater susceptibility to infections in malnourished children . In community studies of children from Guinea Bissau and Bangladesh [7, 8] children with a small thymus had a higher mortality risk, indicating that thymus size could be a marker of immune competence, or perhaps just a marker of good health or robustness. However, factors determining thymus size in children with SAM, or thymus growth with nutritional rehabilitation, have not previously been reported.
Using thymus area as a marker, we found that thymus size was positively associated with most anthropometric indicators of nutritional status. Similar observations have been done among apparently healthy children in Guinea Bissau , Gambia  and Bangladesh , and they confirm the concept of the thymus being a “barometer of malnutrition” . We found that thymus size was negatively associated with acute phase reactants in plasma. This could both reflect acute infections and chronic, low-grade inflammation. Previous studies have suggested that acute infections such as malaria , and neonatal infections  can cause thymus atrophy, and inflammation has recently been reported as a major risk factor for death in children with severe malnutrition . The fact that thymus size was reduced in children with CRP above just 5 mg/l could suggest that low-grade chronic inflammation could also reduce thymus size, although distinguishing between infections and inflammation may be somewhat speculative. Our study confirms that thymus size is reduced by nutritional insults and infections. Both cause elevated levels of cortisol, which animal studies have found to cause thymus atrophy , similar to low levels of leptin . We saw a negative association with care-giver reported severity of illness, similar to a study among newborn children in Guinea Bissau indicating that children who were “not well” according to their mothers, had a smaller thymus, and suggested thymus size to be a general “barometer of good health” . Although malnutrition has been associated with other immune abnormalities, like altered lymphocyte numbers and function, in children , as well as in animal experiments , it is still not known whether thymus size is actually linked to immune function, or whether the association between thymus size and risk of dying is caused by other non-immunological confounding factors, such as diagnosed or undiagnosed infections.
As children admitted with SAM are often both infected and malnourished, it is not surprising that 27% of children in our study had an undetectable thymus on admission. Similarly, an autopsy study of severely malnourished children reported how their thymus was reduced to “an irregular strand of fibrous tissue” . Ultrasound invisibility of the thymus could also be caused by hyper-inflated lungs, (caused by e.g. pneumonia), preventing ultrasound penetration. However, neither reported cough, nor respiratory rate was significantly different in children with or without a visible thymus, suggesting that pneumonia may not be an important cause in this cohort. It is possible that the thymus in some cases would have been visualized in the hands of a more experienced sonographer. However, the fact that we saw similar associations when including invisible thymuses as “invisibly small”, and when including only visible thymuses (in the sensitivity analysis) suggests that it may be reasonable to assume that thymuses were undetectable because they were very small.
Thymus size was positively associated with hemoglobin level, and P-phosphate, which to our knowledge, has not previously been reported. The greater association with phosphate on day two may be explained by the fact that most ultrasound scans were done one or two days after admission, and therefore closer in time to the second blood sample. Infections may cause both anemia and hypophosphatemia , and thus the association could reflect the effect of inflammation on thymus size. However, the associations persisted after adjusting for CRP and AGP. Anemia and hypophosphatemia may be markers of poor nutritional status, although their associations with thymus size remained in the sensitivity analysis adjusting for body size. It is also plausible that hypophosphatemia by itself may contribute to thymus atrophy. Hypophosphatemia has been found to cause leukocyte dysfunction , and phosphorus is a type II nutrient, essential for growth and maintenance of lean body mass . Thymus atrophy occurs in animals deficient in other type II nutrients, like zinc  and magnesium , and a recent study found thymus size in low-birth-weight infants to be associated with zinc levels in cord-blood . However, the association between phosphorous status and immune function has until now not received much attention.
The thymus was smaller in HIV-infected children, although not statistically significant (p = 0.06). It has previously been reported that predominantly well-nourished children with HIV have a smaller thymus . Our findings could be due to low power, with only 15 HIV-positive children in the study.
We found no association between nutritional edema and thymus size. Thymus atrophy is known to occur in children with kwashiorkor , and one study from Egypt reported that children with edematous malnutrition had a smaller thymus that those with non-edematous malnutrition . Others have found higher CD4 counts in edematous than non-edematous children with malnutrition , suggesting that these children had better immunity; however, our data does not indicate that this is reflected by a larger thymus.
Breastfed children did not have a larger thymus, in contrast to previous studies . This could be due to low power, since only 13 of the 85 children were breastfed, or because the association between breastfeeding and thymus size seems to be greatest around 4 months of age, when breastfeeding is exclusive.
Although thymus size recovered with nutritional rehabilitation, it was still significantly smaller than in well-nourished children. This could be because the children’s nutritional status was still poorer that the healthy controls, or because immunological recovery may take longer than anthropometric recovery, as previously suggested .
Few factors predicted change in thymus area. The only anthropometric indicator, in which growth was associated with thymus growth, was MUAC. MUAC reflects muscle mass, and this suggests that recovery of thymus size correlates with recovery of muscle mass. Similar observations were done in a study from Bolivia, where zinc supplementation accelerated both growth in MUAC and growth in thymus size .
Interestingly, children in whom F75 had been replaced by unfortified rice porridge at some point during in-patient treatment had reduced thymus growth at follow-up. Rice porridge was given to about half of the children, during their stay in hospital, when children had diarrhea that worsened after starting refeeding. Confounding by indication is an obvious possibility, but most other indicators of disease severity, such as observed diarrhea, reported severity of illness or capillary refill time were not associated with reduced thymus growth. Rice porridge contains very little vitamins and minerals, virtually no fat, and most of its energy is derived from carbohydrates. In this same cohort, we previously reported that giving rice porridge was associated with lower increase in phosphate over the first two days of nutritional rehabilitation , and also with higher risk of death in hospital . Considering the association between P-phosphate and thymus size, it seems plausible that that the reduced growth could be a consequence of replacing the therapeutic diets with rice porridge. Rice porridge is not part of any established protocol for treatment of SAM or diarrhea, and the practice was stopped at Mwanamugimu Nutrition Unit shortly after the study.
There are a number of limitations to this study: First, its observational design means that we cannot draw firm conclusions about causality. The exploratory approach and the use of multiple testing also means that our findings may only be used to generate hypotheses which should be confirmed in other studies. Second, the most commonly method used previously to measure thymus size is the thymic index, obtained by multiplying the diameter by the area . However, likely due to the severe thymic atrophy, we were mostly unable to visualize the thymus in the transversal projection or to measure the diameter. Therefore, we had to rely on the area measurement only. Our results can therefore not be compared directly to studies using thymic index. Interestingly, other studies of thymus size in children with SAM have, like us, used the thymus area , and our experience suggest that this is the method of choice in children with SAM. Third, we had a rather large loss-to-follow-up, giving low power in the follow-up analyses, and limiting the generalizability of this data, since the children remaining in the study are likely to differ from those lost to follow-up.
A significant proportion of children hospitalized with SAM have no detectable thymus by ultrasound, and these children appear to be sicker than those with a visible thymus. Thymus size is positively associated with anthropometric indicators of nutritional status, with hemoglobin level and phosphate in plasma, and negatively associated with acute phase reactants in plasma. Growth in thymus size at follow-up seems to be associated with increase in MUAC. Children whose F-75 is partially replaced by unfortified cereal may have poorer recovery of thymus size. Our results emphasize the importance of phosphorous in the diets for malnourished children, and suggests further research into the role of phosphate for thymus size and function in children .
α-1 acid glycoprotein
Analysis of co-variance
95% Confidence Interval
Human Immunodeficiency Virus
Severe acute malnutrition
World Health Organization
We are grateful to participating children and caretakers, to Dr. Elizabeth Kiboneka, head of Mwanamugimu Nutrition Unit, for facilitating the study, supervision and guidance, to Sofine Heilskov, Amira Catharina Khatar Sørensen, Kia Hee Schultz and Charlotte Gylling Mortensen for assisting with data collection, and to Julian Eyotaru, Loice Atuhaire, Susan Awori, Justine Naggayi and Joseph Mbabazi for data collection and skilled care of our patients.
The study was funded by a PhD grant from University of Copenhagen to MJHR, as well as by grants from Lundbeck Fonden, Augustinus Fonden, Brødrene Hartmanns Fond, Arvid Nielsens Fond, Axel Muusfeldts Fond, Aase og Einar Danielsens Fond and Torkild Steenbecks Legat. The sponsors of the study had no influence on study design, collection, analysis, or interpretation of data, the writing of the report or the decision to submit the manuscript for publication.
Availability of data and materials
The full dataset used in the current study is available from the corresponding author on reasonable request.
MJHR, HN, KFM and HF conceptualized and designed the study. MJHR and HN conducted the data collection. MJHR performed the ultrasound scans. DLJ provided training in thymus ultrasound scanning, and supervised the technical quality of ultrasound scans during data collection. MJHR, HF and CR performed the data analysis and KFM and AB contributed to the interpretation of data. MJHR wrote the first draft of the manuscript. All authors reviewed and revised the manuscript, and read and approved the final manuscripts as submitted.
The authors declare that they have no competing interests.
Consent for publication
The informed consent signed by caretakers included the permission to publish data from the study.
Ethics approval and consent to participate
The study protocol was approved by Makerere University School of Medicine’s Research Ethics Committee (rec ref 2012–134) and the Uganda National Council of Science and Technology (HS 1246), and the Danish National Board of Research Ethics gave a consultative approval (case no. 1208205). Parents or guardians of malnourished and control children signed a written informed consent form, after oral and written information about the study in English and Luganda.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382:427–51.View ArticlePubMedGoogle Scholar
- Maitland K, Berkley JA, Shebbe M, Peshu N, English M, Newton CRJC. Children with severe malnutrition: can those at highest risk of death be identified with the WHO protocol? PLoS Med. 2006;3:e500.View ArticlePubMedPubMed CentralGoogle Scholar
- Rytter MJH, Kolte L, Briend A, Friis H, Christensen VB. The Immune System in Children with Malnutrition—A Systematic Review. PLoS One. 2014;9:e105017.View ArticlePubMedPubMed CentralGoogle Scholar
- Mugerwa JW. The lymphoreticular system in Kwashiorkor. J Pathol. 1971;105:105–9.View ArticlePubMedGoogle Scholar
- Chevalier P, Sevilla R, Zalles L, Sejas E, Belmonte G, Parent G. Study of thymus and thymocytes in Bolivian preschool children during recovery from severe acute malnutrition. J Nutr Immunol. 1994;3:27–39.View ArticleGoogle Scholar
- Nassar MF, Younis NT, Tohamy AG, Dalam DM, El Badawy MA. T-lymphocyte subsets and thymic size in malnourished infants in Egypt: a hospital-based study. East Mediterr Health J. 2007;13:1031–42. Al-Majallah Al-Ṣiḥḥīyah Li-Sharq Al-Mutawassiṭ.PubMedGoogle Scholar
- Garly M-L, Trautner SL, Marx C, Danebod K, Nielsen J, Ravn H, et al. Thymus size at 6 months of age and subsequent child mortality. J Pediatr. 2008;153:683–8, 688–3.View ArticleGoogle Scholar
- Moore SE, Fulford AJ, Wagatsuma Y, Persson LÅ, Arifeen SE, Prentice AM. Thymus development and infant and child mortality in rural Bangladesh. Int J Epidemiol. 2014;43(1):216–23. doi:10.1093/ije/dyt232. Epub 2013 Dec 23.
- Ministry of Health, Uganda. Integrated management of acute malnutrition guidelines. Kampala: Ministry of Health; 2010.
- WHO, WFP, UNICEF, United Nations System Standing Commitee on Nutrition. Community-based management of severe acute malnutrition - a joint statement by WHO, WFP, the and UNICEF. Geneva: WHO; 2007. Available from: http://apps.who.int/iris/bitstream/10665/44295/1/9789280641479_eng.pdf?ua=1&ua=1.Google Scholar
- WHO. Service delivery approaches to HIV testing and counselling (HTC): a strategic HTC policy framework [Internet]. WHO Press, World Health Organization; 2012. Available from: http://apps.who.int/iris/bitstream/10665/75206/1/9789241593877_eng.pdf?ua=1. Accessed 11 Mar 2017.
- WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76–85.Google Scholar
- Rytter MJ, Namusoke H, Babirekere-Iriso E, Kæstel P, Girma T, Christensen VB, et al. Social, dietary and clinical correlates of oedema in children with severe acute malnutrition: a cross-sectional study. BMC Pediatr. 2015;15:25.
- Namusoke H, Hother A-L, Rytter MJ, Kæstel P, Babirekere-Iriso E, Fabiansen C, et al. Changes in plasma phosphate during in-patient treatment of children with severe acute malnutrition: an observational study in Uganda. Am J Clin Nutr. 2016;103:551–8.View ArticlePubMedGoogle Scholar
- Heilskov S, Vestergaard C, Babirekere E, Ritz C, Namusoke H, Rytter M, et al. Characterization and scoring of skin changes in severe acute malnutrition in children between 6 months and 5 years of age. J Eur Acad Dermatol Venereol. 2015;29:2463–9.View ArticlePubMedGoogle Scholar
- Babirekere-Iriso E, Lauritzen L, Mortensen CG, Rytter M, Mupere E, Namusoke H, et al. Essential fatty acid composition and correlates in children with severe acute malnutrition. Clin Nutr ESPEN. 2016;11:e40–e46.
- Babirekere-Iriso E, Mortensen CG, Mupere E, Rytter MJH, Namusoke H, Michaelsen KF, et al. Changes in whole-blood PUFA and their predictors during recovery from severe acute malnutrition. Br J Nutr. 2016;115:1730–9.View ArticlePubMedGoogle Scholar
- Kristensen KHS, Wiese M, Rytter MJH, Özçam M, Hansen LH, Namusoke H, et al. Gut Microbiota in Children Hospitalized with Oedematous and Non-Oedematous Severe Acute Malnutrition in Uganda. PLoS Negl Trop Dis. 2016;10:e0004369.View ArticlePubMedPubMed CentralGoogle Scholar
- Rytter MJ, Babirekere-Iriso E, Namusoke H, Christensen VB, Michaelsen KF, Ritz C, et al. Risk factors for death in children during inpatient treatment of severe acute malnutrition: a prospective cohort study. Am J Clin Nutr. 2017;105(2):494–502. doi:10.3945/ajcn.116.140822. Epub 2016 Dec 28.
- Collinson AC, Moore SE, Cole TJ, Prentice AM. Birth season and environmental influences on patterns of thymic growth in rural Gambian infants. Acta Paediatr. 2003;92:1014–20.View ArticlePubMedGoogle Scholar
- Moore SE, Prentice AM, Wagatsuma Y, Fulford AJC, Collinson AC, Raqib R, et al. Early-life nutritional and environmental determinants of thymic size in infants born in rural Bangladesh. Acta Paediatr. 2009;98:1168–75.View ArticlePubMedPubMed CentralGoogle Scholar
- Prentice AM. The thymus: a barometer of malnutrition. Br J Nutr. 1999;81:345–7.PubMedGoogle Scholar
- Jeppesen DL, Ersbøll AK, Nielsen SD, Hoppe TU, Valerius NH. Low thymic size in preterm infants in the neonatal intensive care unit, a possible marker of infection? A prospective study from birth to 1 year of age. Acta Paediatr. 2011;100:1319–25.View ArticlePubMedGoogle Scholar
- Attia S, Versloot CJ, Voskuijl W, van Vliet SJ, Di Giovanni V, Zhang L, et al. Mortality in children with complicated severe acute malnutrition is related to intestinal and systemic inflammation: an observational cohort study. Nutr: Am. J. Clin; 2016.Google Scholar
- Savino W, Dardenne M, Velloso LA, Dayse Silva-Barbosa S. The thymus is a common target in malnutrition and infection. Br J Nutr. 2007;98:S11–6.View ArticlePubMedGoogle Scholar
- Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest. 1999;104:1051–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Eriksen HB, Biering-Sørensen S, Lund N, Correia C, Rodrigues A, Andersen A, et al. Factors associated with thymic size at birth among low and normal birth-weight infants. J Pediatr. 2014;165(4):713–21.View ArticlePubMedGoogle Scholar
- Badr G, Sayed D, Alhazza IM, Elsayh KI, Ahmed EA, Alwasel SH. T lymphocytes from malnourished infants are short-lived and dysfunctional cells. Immunobiology. 2011;216:309–15.View ArticlePubMedGoogle Scholar
- Badr G, Mohany M. Maternal perinatal undernutrition attenuates T-cell function in adult male rat offspring. Cell Physiol Biochem. 2011;27:381–90.View ArticlePubMedGoogle Scholar
- Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y. Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med. 1998;104:40–7.View ArticlePubMedGoogle Scholar
- Craddock PR, Yawata Y, VanSanten L, Gilberstadt S, Silvis S, Jacob HS. Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med. 1974;290:1403–7.View ArticlePubMedGoogle Scholar
- Golden MH. Specific deficiencies versus growth failure: type I and type II nutrients. SCN News U N Adm Comm Coord Subcomm Nutr. 1995;(12):10–4.
- Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000;130:1399S–406.PubMedGoogle Scholar
- Malpuech-Brugère C, Nowacki W, Gueux E, Kuryszko J, Rock E, Rayssiguier Y, et al. Accelerated thymus involution in magnesium-deficient rats is related to enhanced apoptosis and sensitivity to oxidative stress. Br J Nutr. 1999;81:405–11.PubMedGoogle Scholar
- Kumar A, Pandey M, Basu S, Shukla RC, Asthana RK. Thymic size correlates with cord blood zinc levels in low-birth-weight newborns. Eur J Pediatr. 2014;173:1083–7.View ArticlePubMedGoogle Scholar
- Chevalier P, Diagbouga S, Traore Y, Cassel-Beraud A-M, Van de Perre P. Thymic size and muscle mass of HIV-infected asymptomatic children from Burkina Faso. J Acquir Immune Defic Syndr. 2002;29:427–8.View ArticlePubMedGoogle Scholar
- Bachou H, Tylleskär T, Downing R, Tumwine JK. Severe malnutrition with and without HIV-1 infection in hospitalised children in Kampala, Uganda: differences in clinical features, haematological findings and CD4+ cell counts. Nutr J. 2006;5:27.View ArticlePubMedPubMed CentralGoogle Scholar
- Hasselbalch H, Jeppesen DL, Engelmann MD, Michaelsen KF, Nielsen MB. Decreased thymus size in formula-fed infants compared with breastfed infants. Acta Paediatr. 1996;85:1029–32.View ArticlePubMedGoogle Scholar
- Chevalier P, Sevilla R, Sejas E, Zalles L, Belmonte G, Parent G. Immune recovery of malnourished children takes longer than nutritional recovery: implications for treatment and discharge. J Trop Pediatr. 1998;44:304–7.View ArticlePubMedGoogle Scholar
- Chevalier P, Sevilla R, Zalles L, Sejas E, Belmonte G. Effect of zinc supplementation on nutritional immune deficiency. Nutr Res. 1996;16:369–79.View ArticleGoogle Scholar
- Hasselbalch H, Ersbøll AK, Jeppesen DL, Nielsen MB. Thymus size in infants from birth until 24 months of age evaluated by ultrasound. A longitudinal prediction model for the thymic index. Acta Radiol. 1999;40:41–4.PubMedGoogle Scholar
- Briend A, Akomo P, Bahwere P, De Pee S, Dibari F, Golden MH, et al. Developing food supplements for moderately malnourished children: lessons learned from ready-to-use therapeutic foods. Food Nutr Bull. 2015;36:S53–8.View ArticlePubMedGoogle Scholar